No, trazodone is NOT a narcotic
Trazodone is classified as an antidepressant medication (specifically a triazolopyridine derivative), not a narcotic or controlled substance. Unlike benzodiazepines used for insomnia which are Schedule IV controlled substances, trazodone is not scheduled by the U.S. Drug Enforcement Administration 1.
Drug Classification
Trazodone's pharmacological profile clearly distinguishes it from narcotics:
- Mechanism of action: Trazodone works primarily as a serotonin antagonist and reuptake inhibitor (SARI), blocking 5-HT2A receptors and inhibiting serotonin reuptake 2
- Not an opioid: While one animal study showed trazodone may interact with mu-opioid receptors 3, this does not make it a narcotic—it remains an antidepressant with a distinct mechanism
- FDA approval: Approved solely for major depressive disorder, though widely used off-label for insomnia 2, 4
Regulatory Status
The evidence consistently shows trazodone's non-controlled status:
- Benzodiazepines (temazepam, triazolam, etc.) are explicitly listed as Schedule IV controlled substances in clinical guidelines 1
- Trazodone appears in these same guidelines under "sedating low-dose antidepressants" with no controlled substance designation 1
- Pitolisant is specifically noted as "the first and only treatment approved for adult patients with narcolepsy with cataplexy that is not scheduled as a controlled substance" 5—trazodone similarly carries no scheduling
Abuse Potential
Research demonstrates trazodone has minimal abuse liability:
- A controlled study in individuals with histories of alcohol and drug abuse found trazodone had significantly less abuse potential than triazolam (a benzodiazepine), with lower scores on measures like "Willing to Take Again" 6
- Trazodone is considered "a relatively safe drug except in massive overdose" with fatalities rarely attributed solely to it at blood concentrations below 9 mg/L 7
- Large-scale poison center data (118,773 cases) showed 59.5% of trazodone exposures required no medical admission, with most experiencing mild-moderate effects 8
Clinical Context
Important distinction: The term "narcotic" specifically refers to opioid medications (morphine, oxycodone, etc.) or, in legal contexts, any controlled substance. Trazodone fits neither definition. While it has sedative properties and is commonly prescribed for sleep disturbances 9, 5, this does not make it a narcotic—many non-controlled medications cause sedation.
Guidelines explicitly recommend against benzodiazepines for chronic insomnia due to dependency risks 10, while trazodone, despite limited efficacy evidence, is discussed as an alternative option without such scheduling concerns 11, 10.